References
- Bandara V, Weinstein SA, White J, Eddleston M. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon 2010;56:273–81. doi: 10.1016/j.toxicon.2010.03.026
- Botelho AFM, Pierezan F, Soto-Blanco B, Melo MM. A review of cardiac glycosides: structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential. Toxicon 2019;158:63–8. doi: 10.1016/j.toxicon.2018.11.429
- Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 2008;7:926–35. doi: 10.1038/nrd2682
- Osterloh J, Herold S, Pond S. Oleander interference in the digoxin radioimmunoassay in a fatal ingestion. JAMA 1982;247:1596–7. doi: 10.1001/jama.1982.03320360046030
- Peymani P, Zamiri N, Tahmasbi J. A case of non-fatal oleander poisoning. Iran Red Crescent Med J 2011;13:219–20.
- Senthilkumaran S, Meenakshisundaram R, Michaels AD, Thirumalaikolundusubramanian P. Electrocardiographic changes during inhalational oleander toxicity. J Electrocardiol 2011;44:470–2. doi: 10.1016/j.jelectrocard.2010.12.002
- Küçükdurmaz Z, Karapinar H, Gül I, Yilmaz A. Complete atrioventricular block after self-ingestion of Nerium oleander for relief of hemorrhoidal complaints. Turk Kardiyol Dern Ars 2012;40:168–70. doi: 10.5543/tkda.2012.01703
- Le Couteur DG, Fisher AA. Chronic and criminal administration of Nerium oleander. J Toxicol Clin Toxicol 2002;40:523–4. PMID: 12217009
- Eddleston M, Ariaratnam CA, Sjöström L, Jayalath S, Rajakanthan K, Rajapakse S, Colbert D, Meyer WP, Perera G, Attapattu S, Kularatne SA, Sheriff MR, Warrell DA. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital. Heart 2000;83:301–6. doi: 10.1136/heart.83.3.301
- Varga A, Puschner B. Retrospective study of cattle poisonings in California: recognition, diagnosis, and treatment. Vet Med Res Rep 2012;3:111–27. doi: 10.2147/VMRR.S28770
- Galey FD, Holstege DM, Plumlee KH, Tor E, Johnson B, Anderson ML, Blanchard PC, Brown F. Diagnosis of oleander poisoning in livestock. J Vet Diagn Invest 1996;8:358–64. doi: 10.1177/104063879600800314
- Shaw D, Pearn J. Oleander poisoning. Med J Aust 1979;2:267–9. doi: 10.5694/j.1326-5377.1979.tb127135.x
- Bavunoğlu I, Balta M, Türkmen Z. Oleander poisoning as an example of self-medication attempt. Balkan Med J 2016;33:559–62. doi: 10.5152/balkanmedj.2016.150307
- Saravanapavananthan N, Ganeshamoorthy J. Yellow oleander poisoning - a study of 170 cases. Forensic Sci Int 1988;36:247–50. doi: 10.1016/0379-0738(88)90150-8
- Wasfi IA, Zorob O, Al Katheeri NA, Al Awadhi AM. A fatal case of oleandrin poisoning. Forensic Sci Int 2008;179(2–3):e31–6. doi: 10.1016/j.forsciint.2008.05.002
- Carfora A, Petrella R, Borriello R, Aventaggiato L, Gagliano-Candela R, Campobasso CP. Fatal poisoning by ingestion of a self-prepared oleander leaf infusion. Forensic Sci Med Pathol 2021;17:120–5. doi: 10.1007/s12024-020-00338-w
- Rajapakse S. Management of yellow oleander poisoning. Clin Toxicol 2009;47:206–12. doi: 10.1080/15563650902824001
- Shumaik GM, Wu AW, Ping AC. Oleander poisoning: treatment with digoxin-specific Fab antibody fragments. Ann Emerg Med 1988;17:732–5. doi: 10.1016/s0196-0644(88)80625-5
- Eddleston M, Ariaratnam CA, Meyer WP, Perera G, Kularatne AM, Attapattu S, Sheriff MH, Warrell DA. Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Trop Med Int Health 1999;4:266–73. doi: 10.1046/j.1365-3156.1999.00397.x
- Azzalini E, Bernini M, Vezzoli S, Antonietti A, Verzeletti A. A fatal case of self-poisoning through ingestion of oleander leaves. J Forensic Leg Med 2019;65:133–6. doi: 10.1016/j.jflm.2019.05.016
- Taskin O, Belli F, Acikalin A, Disel NR. Add oleander to your list of corrosives. Turk J Emerg Med 2019;19:115–6. doi: 10.1016/j.tjem.2018.12.002
- Camphausen C, Haas NA, Mattke AC. Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature. Z Kardiol 2005;94:817–23. doi: 10.1007/s00392-005-0293-3
- Eddleston M, Rajapakse S, Rajakanthan Jayalath S, Sjöström L, Santharaj W, Thenabadu PN, Sheriff MH, Warrell DA. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet 2000;355:967–72. doi: 10.1016/s0140-6736(00)90014-x
- U.S. Food and Drug Administration. DigiFab. Digoxin Immune Fab (Ovine) [displayd 15 April 2023]. Available at
https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/digifab - Wei SK, Niu MT, Dores GM. Adverse events associated with use of Digoxin immune Fab reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019. Drugs Real World Outcomes 2021;8:253–62. doi: 10.1007/s40801-021-00242-x
- Ward SB, Sjöström L, Ujhelyi MR. Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind. Ther Drug Monit 2000;22:599–607. doi: 10.1097/00007691-200010000-00016